Skip to main content
. 2024 Jun 19;66(6):528–537. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_123_24

Table 3.

Comparison of sociodemographic and clinical characteristics between psychiatric/addiction service consultation and other medical consultation in first contact

Parameter Psychiatric/Addiction related consultation (PAC) (Mean±SD) (n=631) Other medical consultation (OMC) (Mean±SD) (n=196) U/χ2/F df P
Sociodemographic variables
    Age in years (n=822) 33.4±11.9 39.8±11.5 82213 820 <.001
    Education in years (n=820) 11.1±4.4 10±4.4 50842.5 818 0.001
Gender (n=827)
    Male 622 (98.6) 190 (97) 6.4 2 0.051
    Female 7 (1.1) 4 (2)
    Others 2 (0.3) 2 (1)
Indigenous population (n=827)
    Yes 96 (15.2) 18 (9.2) 4.6 1 0.03
    No/Not known 535 (84.8) 178 (90.8)
Marital status (n=827)
    Married 364 (57.7) 148 (75.5) 20.1 1 <.001
    Not married 267 (41.7) 48 (24.5)
Occupation (n=827)
    UE/unskilled/household/semiskilled 257 (40.7) 81 (41.3) 0.02 1 0.88
    Others 374 (59.3) 115 (58.7)
Socioeconomic status (n=730)
    Lower-middle 30 (5.5) 14 (7.8) 2.05 3 0.56
    Middle 114 (20.7) 32 (17.8)
    Upper-middle 367 (66.7) 123 (68.3)
    Upper 39 (7.1) 11 (6.1)
Locality (n=811)
    Rural 295 (47.5) 113 (59.5) 8.3 1 0.004
    Urban 326 (52.5) 77 (40.5)
Clinical variables
    Duration of use in months (n=814) 118.1±117.6 170.6±118.5 78635 812 <.001
    Duration of dependence in months (n=792) 81.1±93.1 112.1±84.5 76644 790 <.001
Primary substance (n=827)
    Alcohol 176 (27.9) 140 (71.4)† 121 2 <.001
    Opioid 412 (65.3)* 47 (24)
    Others 43 (6.8) 9 (4.6)
Secondary substance (n=504)
    Tobacco 255 (66.4) 101 (84.2)‡ 15.3 3 0.002
    Cannabis 79 (20.6)§ 9 (7.5)
    Alcohol 37 (9.6) 6 (5)
    Others 13 (3.4) 4 (3.3)
Medical comorbidity (n=827)
    Absent 552 (87.5) 128 (65.3) 50.3 1 < 0.001
    Present 79 (12.5) 92 (34.7)
HCV seropositivity (n=827)
    Absent 613 (97.1) 193 (98.5) 1.1 1 0.44
    Present 18 (2.9) 3 (1.5)
First symptom profile
Compulsion (n=808)
    Yes 381 (61.7) 88 (46.3) 14 1 <.001
    No 237 (38.3) 102 (53.7)
Tolerance (n=808)
    Yes 125 (20.2) 48 (25.3) 2.2 1 0.14
    No 493 (79.8) 142 (74.7)
Withdrawal (n=808)
    Yes 101 (16.3) 67 (35.3) 31.6 1 < 0.001
    No 517 (83.7) 123 (64.7)
Loss of control (n=808)
    Yes 83 (13.4) 46 (24.2) 12.6 1 0.001
    No 535 (86.6) 144 (75.8)
Neglect (n=808)
    Yes 9 (1.5) 6 (3.2) 2.3 1 0.13
    No 609 (98.5) 184 (96.8)
Use despite harm (n=808)
    Yes 12 (1.9) 20 (10.5) 28.2 1 <.001
    No 606 (98.1) 170 (89.5)
How long ago did the first contact occur (weeks) (n=800) 55.9±102.2 166.3±220.7 86087 798 <.001
First Symptom first contact interval (weeks) (n=798) 283.8±397.7 308.7±368.3 59801 796 0.56

*Standardised adjusted residual=10. Standardised adjusted residual=11. Standardised adjusted residual=3.7. §Standardised adjusted residual=3.3